Mycenax Biotech Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 292.217 million compared to TWD 69.861 million a year ago. Operating income was TWD 114.678 million compared to operating loss of TWD 25.923 million a year ago. Net income was TWD 114.386 million compared to net loss of TWD 21.603 million a year ago. Basic earnings per share from continuing operations was TWD 0.85 compared to basic loss per share from continuing operations of TWD 0.17 a year ago.